La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Titre (en) » - entrée « action »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
acting < action < actionability  Facettes :

List of bibliographic references indexed by action

Number of relevant bibliographic references: 31.
[20-40] [0 - 20][0 - 31]
Ident.Authors (with country if any)Title
002B14 (2005) Shawn Hayley [Canada] ; Hymie Anisman [Canada]Multiple mechanisms of cytokine action in neurodegenerative and psychiatric states: Neurochemical and molecular substrates : The role of cytokines in neurodegeneration and psychiatric conditions: Multiple mechanisms of action
002F82 (2002) Philip Seeman [Canada]Atypical antipsychotics: mechanism of action.
003702 (1999) Zuping Xia [Canada] ; Leonard I. Wiebe [Canada] ; Gerald G. Miller [Canada] ; Edward E. KnausSynthesis and Biological Evaluation of Butanoate, Retinoate, and Bis(2,2,2‐trichloroethyl)phosphate Derivatives of 5‐Fluoro‐2′‐deoxyuridine and 2′,5‐Difluoro‐2′‐deoxyuridine as Potential Dual Action Anticancer Prodrugs
004037 (1995) Zhiguo Wang [Canada] ; Jianlin Feng [Canada] ; Stanley Nattel [Canada]Idiopathic atrial fibrillation in dogs: Electrophysiologic determinants and mechanisms of antiarrhythmic action of flecainide
004629 (1992) H. A. Robertson [Canada]Synergistic interactions of D1- and D2-selective dopamine agonists in animal models for Parkinson's disease : sites of action and implications for the pathogenesis of dyskinesias
004754 (1991) G. J. Tatton [Canada] ; C. E. Greenwood [Canada]Rescue of dying neurons: A new action for deprenyl in MPTP parkinsonism
004815 (1991) W. G. Tatton [Canada] ; C. E. GreenwoodRescue of dying neurons : a new action for deprenyl in MPTP parkinsonism
004C63 (1988) R. J. RiopelleAdrenal medulla autografts in Parkinson's disease: a proposed mechanism of action
004C84 (1987) H A Robertson [Canada] ; G S RobertsonCombined L-dopa and bromocriptine therapy for Parkinson's disease: a proposed mechanism of action.
004D90 (1987) H. A. Robertson ; G. S. RobertsonHypothesis. Combined L-dopa and bromocriptine therapy for Parkinson's disease: a proposed mechanism of action
005618 (????) Frédéric Calon [Canada] ; Greg ColeNeuroprotective action of omega-3 polyunsaturated fatty acids against neurodegenerative diseases: evidence from animal studies.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "action" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "action" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    action
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022